Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (783)	5/19/1999 4:20:00 PM
From: Rick Strange	Respond to of 1386

Yesterday I e-mailed the PARS IR Dept and asked if Lotemax could be used in LASIX and other vision correction surgeries. Gale Smith, Investor Relations, wrote back: "The approval of Lotemax received in June 1998 covers use of Lotemax to treat opthalmic inflammation resulting from a number of causes and does in fact include LASIX and other vision correction surgeries." She also informed me that the 1998 annual report will be available Monday, May 24th. The are going to try to put it on the web site but if that doesn't work out it'll be available via Edgar.